Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy
Neuroimmunomodulation · 31.03.2026 · 33 (1) · 213-224
DOI: 10.1159/000551742 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuroimmunomodulation, online erschienen am 31.03.2026. Verfasst von Fabiana Santos Pacheco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cru…. Hauptthemen laut MEDLINE: Glucocorticoids, Neutrophils, Drug Resistance. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: Neutrophils are the most abundant leukocytes in peripheral circulation and play a crucial role in combating infections and mediating inflammatory responses. Neutrophils are produced in bone marrow, have a short half-life in the blood, and are rapidly attracted to the tissues in response to infection or tissue damage. Summary: Glucocorticoids (GCs), stress hormones, and potent anti-inflammatory agents exert complex effects on neutrophils. While they generally suppress immune responses, GCs can paradoxically enhance neutrophil survival and function under certain conditions. This duality is evident in their ability to delay neutrophil apoptosis and to induce a shift of neutrophils from the marginated to the circulating pool, increasing the neutrophil presence in the bloodstream. Th17 cells, a subset of T-helper cells, recruit neutrophils to sites of infection and inflammation. In addition, neutrophils promote Th17 cell differentiation. GCs can enhance Th17 differentiation and IL-17 production, exacerbating neutrophil accumulation. Nevertheless, in glucocorticoid-resistant diseases, including multiple sclerosis (MS), traumatic brain injury (TBI), and encephalomyelitis, Th17 cells and neutrophils contribute to persistent inflammation. This resistance complicates the treatment of autoimmune diseases and chronic inflammatory disorders, also in the central nervous system, where standard glucocorticoid therapy fails to mitigate symptoms effectively. Key Messages: In this context, we propose a mechanism for the development of resistance to GC driving by uncontrolled TH17 response and neutrophils induced by chronic stress. Understanding the interactions between neutrophils, Th17 cells, and GCs is essential for developing targeted therapies for diseases resistant to GC, such as MS, TBI, and encephalomyelitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
- Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
- Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
- National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
- Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.
- National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.
Zitieren
APA
Pacheco, F. S., da Rocha Mota, R. G., Pinho Jannini de Sá, Y. A., Hogaboam, C. M., Castro-Faria-Neto, H. C., & Carvalho, V. F. (2026). Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy. Neuroimmunomodulation, 33(1), 213-224. https://doi.org/10.1159/000551742
Vancouver
Pacheco FS, da Rocha Mota RG, Pinho Jannini de Sá YA, Hogaboam CM, Castro-Faria-Neto HC, Carvalho VF. Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy. Neuroimmunomodulation. 2026;33(1):213-224. doi:10.1159/000551742
BibTeX
@article{Pacheco2026,
author = {Pacheco, Fabiana Santos and da Rocha Mota, Rayssa Garcia and Pinho Jannini de Sá, Yago Amigo and Hogaboam, Cory M and Castro-Faria-Neto, Hugo Caire and Carvalho, Vinicius Frias},
title = {Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy},
journal = {Neuroimmunomodulation},
year = {2026},
volume = {33},
number = {1},
pages = {213--224},
doi = {10.1159/000551742}
}
EUVIMED